KARYOPHARM THERAPEUTICS INC (KPTI) Stock Earnings & Estimates
USA - NASDAQ:KPTI - US48576U2050 - Common Stock
5.68 USD
+0.18 (+3.27%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 157.1M -25.12% | 146.033M -7.04% | 145.237M -0.55% | 152.31M 4.87% | 166.32M 9.20% | 221.2M 33.00% | 388.6M 75.68% | 305.58M -21.36% | 379.54M 24.20% | 446.98M 17.77% | 486.65M 8.88% | |
| EBITDA YoY % growth | -141.58M -45.20% | -129.01M 8.88% | -119.103M 7.68% | -132.6M -11.33% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -142.2M -44.66% | -129.54M 8.90% | -119.443M 7.79% | -104.363M 12.62% | -92.317M 11.54% | -40.338M 56.30% | -66.082M -63.82% | -3.741M 94.34% | 61.002M 1,730.48% | 122.41M 100.67% | 157.04M 28.29% | |
| Operating Margin | -90.52% | -88.71% | -82.24% | -68.52% | -55.51% | -18.24% | -17.01% | -1.22% | 16.07% | 27.39% | 32.27% | |
| EPS YoY % growth | -30.45 -18.71% | -18.75 38.42% | -10.05 46.40% | -11.30 -12.48% | -5.71 49.53% | -2.89 49.32% | -2.52 12.87% | 0.31 112.15% | 1.96 540.00% | 3.38 72.40% | 4.04 19.64% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.90 47.31% | -2.09 24.51% | -4.83 -11.92% | -4.62 -20.96% | -4.39 -131.24% |
| Revenue Q2Q % growth | 37.452M 22.62% | 36.211M 20.64% | 37.74M -0.50% | 41.31M -6.21% | 44.88M 19.83% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.251M 25.67% | -26.206M 21.20% | -30.212M -23.89% | -28.208M -85.34% | -26.204M -12.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -3.82 2.05% | -3.19 | -0.63 | -19.63% |
| Q2 2025 Q2Q % growth | -4.32 -292.00% | -4.18 | -0.14 | -3.34% |
| Q1 2025 Q2Q % growth | -2.77 42.29% | -4.26 | 1.49 | 35.04% |
| Q4 2024 Q2Q % growth | -3.60 33.33% | -4.00 | 0.40 | 10.00% |
| Q3 2024 Q2Q % growth | -3.90 13.33% | -4.02 | 0.12 | 3.03% |
| Q2 2024 Q2Q % growth | 2.25 151.72% | -4.57 | 6.82 | 149.25% |
| Q1 2024 Q2Q % growth | -4.80 -6.67% | -5.11 | 0.31 | 6.03% |
| Q4 2023 Q2Q % growth | -5.40 16.28% | -4.74 | -0.66 | -13.96% |
| Q3 2023 Q2Q % growth | -4.50 33.33% | -4.28 | -0.22 | -5.04% |
| Q2 2023 Q2Q % growth | -4.35 53.23% | -5.24 | 0.89 | 16.92% |
| Q1 2023 Q2Q % growth | -4.50 43.40% | -5.63 | 1.13 | 20.12% |
| Q4 2022 Q2Q % growth | -6.45 -193.48% | -5.40 | -1.05 | -19.42% |
| Q3 2022 Q2Q % growth | -6.75 34.78% | -8.65 | 1.90 | 21.99% |
| Q2 2022 Q2Q % growth | -9.30 12.68% | -9.69 | 0.39 | 4.02% |
| Q1 2022 Q2Q % growth | -7.95 31.17% | -9.65 | 1.70 | 17.65% |
| Q4 2021 Q2Q % growth | 6.90 177.97% | -7.89 | 14.79 | 187.47% |
| Q3 2021 Q2Q % growth | -10.35 5.48% | -10.30 | -0.05 | -0.47% |
| Q2 2021 Q2Q % growth | -10.65 -12.70% | -11.46 | 0.81 | 7.07% |
| Q1 2021 Q2Q % growth | -11.55 1.28% | -10.88 | -0.67 | -6.17% |
| Q4 2020 Q2Q % growth | -8.85 22.37% | -9.06 | 0.21 | 2.29% |
| Q3 2020 Q2Q % growth | -10.95 -8.96% | -11.06 | 0.11 | 1.01% |
| Q2 2020 Q2Q % growth | -9.45 11.27% | -8.89 | -0.56 | -6.31% |
| Q1 2020 Q2Q % growth | -11.70 28.44% | -10.61 | -1.09 | -10.23% |
| Q4 2019 Q2Q % growth | -11.40 | -10.25 | -1.15 | -11.21% |
| Q3 2019 Q2Q % growth | -10.05 | -12.64 | 2.59 | 20.50% |
| Q2 2019 Q2Q % growth | -10.65 | -15.06 | 4.41 | 29.29% |
| Q1 2019 Q2Q % growth | -16.35 | -13.33 | -3.02 | -22.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 44.044M 13.57% | 42.036M | 2.008M | 4.78% |
| Q2 2025 Q2Q % growth | 37.929M -11.35% | 37.674M | 255K | 0.68% |
| Q1 2025 Q2Q % growth | 30.015M -9.39% | 35.947M | -5.932M | -16.50% |
| Q4 2024 Q2Q % growth | 30.542M -9.50% | 35.562M | -5.02M | -14.12% |
| Q3 2024 Q2Q % growth | 38.783M 7.70% | 38.544M | 239K | 0.62% |
| Q2 2024 Q2Q % growth | 42.786M 13.86% | 36.903M | 5.883M | 15.94% |
| Q1 2024 Q2Q % growth | 33.126M -14.40% | 35.162M | -2.036M | -5.79% |
| Q4 2023 Q2Q % growth | 33.747M 0.44% | 36.113M | -2.366M | -6.55% |
| Q3 2023 Q2Q % growth | 36.009M -0.25% | 38.025M | -2.016M | -5.30% |
| Q2 2023 Q2Q % growth | 37.579M -5.34% | 36.736M | 843K | 2.29% |
| Q1 2023 Q2Q % growth | 38.698M -18.87% | 37.337M | 1.361M | 3.65% |
| Q4 2022 Q2Q % growth | 33.6M -73.40% | 35.821M | -2.221M | -6.20% |
| Q3 2022 Q2Q % growth | 36.1M -4.24% | 35.253M | 847K | 2.40% |
| Q2 2022 Q2Q % growth | 39.7M 75.66% | 36.303M | 3.397M | 9.36% |
| Q1 2022 Q2Q % growth | 47.7M 104.72% | 34.854M | 12.846M | 36.86% |
| Q4 2021 Q2Q % growth | 126.3M 259.83% | 40.868M | 85.432M | 209.04% |
| Q3 2021 Q2Q % growth | 37.7M 77.00% | 26.32M | 11.38M | 43.24% |
| Q2 2021 Q2Q % growth | 22.6M -32.54% | 26.153M | -3.553M | -13.59% |
| Q1 2021 Q2Q % growth | 23.3M 28.73% | 25.672M | -2.372M | -9.24% |
| Q4 2020 Q2Q % growth | 35.1M 93.92% | 29.961M | 5.139M | 17.15% |
| Q3 2020 Q2Q % growth | 21.3M 62.60% | 21.882M | -582K | -2.66% |
| Q2 2020 Q2Q % growth | 33.5M 252.63% | 27.97M | 5.53M | 19.77% |
| Q1 2020 Q2Q % growth | 18.1M 8,950.00% | 21.708M | -3.608M | -16.62% |
| Q4 2019 Q2Q % growth | 18.1M | 16.667M | 1.433M | 8.60% |
| Q3 2019 Q2Q % growth | 13.1M | 1.838M | 11.262M | 612.73% |
| Q2 2019 Q2Q % growth | 9.5M | 96.104K | 9.404M | 9,785.08% |
| Q1 2019 Q2Q % growth | 200K | 334.662K | -134.662K | -40.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.81% | 8.96% | -1.11% | 9.04% |
| Revenue | 5.18% | 6.74% | 1.43% | 2.63% |